avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.18 | Tgif1 |
Meis3
|
ENSMUSG00000041420.19 | Meis3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis3 | mm39_v1_chr7_+_15909283_15909362 | -0.75 | 1.5e-07 | Click! |
Tgif1 | mm39_v1_chr17_-_71160477_71160543 | -0.54 | 6.0e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_39275518 | 31.84 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr7_-_97066937 | 29.27 |
ENSMUST00000043077.8
|
Thrsp
|
thyroid hormone responsive |
chr2_+_155359868 | 20.95 |
ENSMUST00000029135.15
ENSMUST00000065973.9 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr2_+_155360015 | 18.65 |
ENSMUST00000103142.12
|
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr7_-_30623592 | 17.91 |
ENSMUST00000217812.2
ENSMUST00000074671.9 |
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr11_-_5900019 | 17.55 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr5_-_87485023 | 17.26 |
ENSMUST00000031195.3
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr15_+_6474808 | 13.88 |
ENSMUST00000022749.17
ENSMUST00000239466.2 |
C9
|
complement component 9 |
chrX_+_10118544 | 13.39 |
ENSMUST00000049910.13
|
Otc
|
ornithine transcarbamylase |
chr2_+_102536701 | 12.03 |
ENSMUST00000123759.8
ENSMUST00000005220.11 ENSMUST00000111212.8 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chrX_+_10118600 | 11.26 |
ENSMUST00000115528.3
|
Otc
|
ornithine transcarbamylase |
chr10_+_87696339 | 10.57 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr1_+_130754413 | 9.68 |
ENSMUST00000027675.14
ENSMUST00000133792.8 |
Pigr
|
polymeric immunoglobulin receptor |
chr16_+_26400454 | 9.39 |
ENSMUST00000096129.9
ENSMUST00000166294.9 ENSMUST00000174202.8 ENSMUST00000023156.13 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr19_-_46661501 | 8.97 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr5_-_87074380 | 8.94 |
ENSMUST00000031183.3
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr1_-_121255400 | 8.93 |
ENSMUST00000159085.8
ENSMUST00000159125.2 ENSMUST00000161818.2 |
Insig2
|
insulin induced gene 2 |
chr1_-_121255448 | 8.83 |
ENSMUST00000186915.2
ENSMUST00000160968.8 ENSMUST00000162582.2 |
Insig2
|
insulin induced gene 2 |
chr7_-_25176959 | 8.80 |
ENSMUST00000098668.3
ENSMUST00000206687.2 ENSMUST00000206676.2 ENSMUST00000205308.2 ENSMUST00000098669.8 ENSMUST00000206171.2 ENSMUST00000098666.9 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr19_-_46661321 | 8.41 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr10_+_87695352 | 8.27 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr7_+_46401214 | 8.21 |
ENSMUST00000210769.2
ENSMUST00000210272.2 ENSMUST00000075982.4 |
Saa2
|
serum amyloid A 2 |
chr12_+_104304631 | 8.12 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr11_+_98239230 | 8.00 |
ENSMUST00000078694.13
|
Ppp1r1b
|
protein phosphatase 1, regulatory inhibitor subunit 1B |
chr7_-_46392403 | 7.97 |
ENSMUST00000128088.4
|
Saa1
|
serum amyloid A 1 |
chr6_-_85846110 | 7.85 |
ENSMUST00000045008.8
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
chr9_+_74860335 | 7.81 |
ENSMUST00000170846.8
|
Fam214a
|
family with sequence similarity 214, member A |
chr8_+_105810380 | 7.80 |
ENSMUST00000093221.13
ENSMUST00000074403.13 |
Ces3b
|
carboxylesterase 3B |
chr3_-_107893676 | 7.68 |
ENSMUST00000066530.7
ENSMUST00000012348.9 |
Gstm2
|
glutathione S-transferase, mu 2 |
chr4_+_115268821 | 7.59 |
ENSMUST00000094887.4
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr9_-_71678814 | 7.53 |
ENSMUST00000122065.2
ENSMUST00000121322.8 ENSMUST00000072899.9 |
Cgnl1
|
cingulin-like 1 |
chr19_+_20470056 | 7.47 |
ENSMUST00000225337.3
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr10_+_128089965 | 7.35 |
ENSMUST00000060782.5
ENSMUST00000218722.2 |
Apon
|
apolipoprotein N |
chr8_+_129085719 | 7.26 |
ENSMUST00000026917.10
|
Nrp1
|
neuropilin 1 |
chr6_-_138013901 | 7.22 |
ENSMUST00000150278.3
|
Slc15a5
|
solute carrier family 15, member 5 |
chr3_-_88332401 | 7.22 |
ENSMUST00000168755.7
ENSMUST00000193433.6 ENSMUST00000195657.6 ENSMUST00000057935.9 |
Slc25a44
|
solute carrier family 25, member 44 |
chr1_+_16175998 | 7.16 |
ENSMUST00000027053.8
|
Rdh10
|
retinol dehydrogenase 10 (all-trans) |
chr19_+_20470114 | 7.10 |
ENSMUST00000225313.2
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr19_-_20704896 | 6.90 |
ENSMUST00000025656.4
|
Aldh1a7
|
aldehyde dehydrogenase family 1, subfamily A7 |
chr9_+_108569315 | 6.77 |
ENSMUST00000035220.12
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr15_+_10216041 | 6.75 |
ENSMUST00000130720.8
|
Prlr
|
prolactin receptor |
chr15_+_9279915 | 6.68 |
ENSMUST00000022861.9
|
Ugt3a1
|
UDP glycosyltransferases 3 family, polypeptide A1 |
chr10_+_87695886 | 6.66 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr11_-_11840367 | 6.61 |
ENSMUST00000155690.2
|
Ddc
|
dopa decarboxylase |
chr1_-_180023518 | 6.59 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr15_+_4756684 | 6.52 |
ENSMUST00000161997.8
ENSMUST00000022788.15 |
C6
|
complement component 6 |
chr1_-_180023467 | 6.49 |
ENSMUST00000161746.2
ENSMUST00000160879.7 |
Coq8a
|
coenzyme Q8A |
chr8_+_107877252 | 6.42 |
ENSMUST00000034400.5
|
Cyb5b
|
cytochrome b5 type B |
chr15_+_4756657 | 6.38 |
ENSMUST00000162585.8
|
C6
|
complement component 6 |
chr10_+_62756409 | 6.34 |
ENSMUST00000044977.10
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr2_-_160714473 | 6.31 |
ENSMUST00000103111.9
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr4_-_155430153 | 6.28 |
ENSMUST00000103178.11
|
Prkcz
|
protein kinase C, zeta |
chr2_+_71811526 | 6.26 |
ENSMUST00000090826.12
ENSMUST00000102698.10 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr8_-_72966840 | 6.25 |
ENSMUST00000238973.2
|
Cib3
|
calcium and integrin binding family member 3 |
chr9_+_108569489 | 6.18 |
ENSMUST00000195405.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr19_+_12610870 | 6.17 |
ENSMUST00000119960.2
|
Glyat
|
glycine-N-acyltransferase |
chr7_-_140590605 | 6.12 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr15_-_60793115 | 6.05 |
ENSMUST00000096418.5
|
A1bg
|
alpha-1-B glycoprotein |
chr3_+_94284739 | 6.04 |
ENSMUST00000197040.5
|
Rorc
|
RAR-related orphan receptor gamma |
chr19_-_7779943 | 5.84 |
ENSMUST00000120522.8
|
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr15_+_9335636 | 5.82 |
ENSMUST00000072403.7
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr19_-_40062174 | 5.82 |
ENSMUST00000048959.5
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr3_+_94284812 | 5.79 |
ENSMUST00000200009.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr13_-_4573312 | 5.78 |
ENSMUST00000221564.2
ENSMUST00000078239.5 ENSMUST00000080361.13 |
Akr1c20
|
aldo-keto reductase family 1, member C20 |
chr11_-_11840394 | 5.74 |
ENSMUST00000109659.9
|
Ddc
|
dopa decarboxylase |
chr19_+_58658779 | 5.69 |
ENSMUST00000057270.9
|
Pnlip
|
pancreatic lipase |
chr7_-_99345016 | 5.67 |
ENSMUST00000107086.9
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr8_+_110717062 | 5.67 |
ENSMUST00000001720.14
ENSMUST00000143741.2 |
Tat
|
tyrosine aminotransferase |
chr10_+_87695117 | 5.62 |
ENSMUST00000105300.9
|
Igf1
|
insulin-like growth factor 1 |
chr1_+_131890679 | 5.59 |
ENSMUST00000191034.2
ENSMUST00000177943.8 |
Gm29103
Slc45a3
|
predicted gene 29103 solute carrier family 45, member 3 |
chr4_-_96552349 | 5.55 |
ENSMUST00000030299.8
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr8_+_84699580 | 5.54 |
ENSMUST00000005606.8
|
Prkaca
|
protein kinase, cAMP dependent, catalytic, alpha |
chr14_+_40827108 | 5.53 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr8_+_105652867 | 5.52 |
ENSMUST00000034355.11
ENSMUST00000109410.4 |
Ces2e
|
carboxylesterase 2E |
chr17_-_13159204 | 5.52 |
ENSMUST00000043923.12
|
Acat3
|
acetyl-Coenzyme A acetyltransferase 3 |
chrX_-_112095181 | 5.46 |
ENSMUST00000026607.15
ENSMUST00000113388.3 |
Chm
|
choroidermia (RAB escort protein 1) |
chr1_+_167445815 | 5.43 |
ENSMUST00000111380.2
|
Rxrg
|
retinoid X receptor gamma |
chr6_-_85892586 | 5.37 |
ENSMUST00000174369.3
|
Nat8f1
|
N-acetyltransferase 8 (GCN5-related) family member 1 |
chr15_+_100202021 | 5.35 |
ENSMUST00000230472.2
|
Mettl7a1
|
methyltransferase like 7A1 |
chr10_+_116137277 | 5.31 |
ENSMUST00000092167.7
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr15_-_96929086 | 5.23 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr5_+_137979763 | 5.20 |
ENSMUST00000035390.7
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chrX_+_59044796 | 5.19 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr15_+_7120089 | 5.15 |
ENSMUST00000228723.2
|
Lifr
|
LIF receptor alpha |
chr10_-_115198093 | 5.12 |
ENSMUST00000219890.2
ENSMUST00000218731.2 ENSMUST00000217887.2 ENSMUST00000092170.7 |
Tmem19
|
transmembrane protein 19 |
chr18_-_75094323 | 5.08 |
ENSMUST00000066532.5
|
Lipg
|
lipase, endothelial |
chr10_+_62756426 | 5.08 |
ENSMUST00000144459.2
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr19_+_12610668 | 5.06 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chr15_+_100202061 | 5.05 |
ENSMUST00000229574.2
ENSMUST00000229217.2 |
Mettl7a1
|
methyltransferase like 7A1 |
chr7_-_114162125 | 5.03 |
ENSMUST00000211506.2
ENSMUST00000119712.8 ENSMUST00000032908.15 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr2_-_84573999 | 5.01 |
ENSMUST00000181711.2
|
Gm19426
|
predicted gene, 19426 |
chr19_+_58658838 | 5.00 |
ENSMUST00000238108.2
|
Pnlip
|
pancreatic lipase |
chr14_+_28740162 | 4.98 |
ENSMUST00000055662.4
|
Lrtm1
|
leucine-rich repeats and transmembrane domains 1 |
chr19_-_8382424 | 4.95 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr7_-_132178101 | 4.94 |
ENSMUST00000084500.8
|
Oat
|
ornithine aminotransferase |
chr5_-_87402659 | 4.89 |
ENSMUST00000075858.4
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr2_-_160714749 | 4.77 |
ENSMUST00000176141.8
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr15_+_31224616 | 4.77 |
ENSMUST00000186547.7
|
Dap
|
death-associated protein |
chr10_+_87694924 | 4.75 |
ENSMUST00000095360.11
|
Igf1
|
insulin-like growth factor 1 |
chr18_+_56565188 | 4.73 |
ENSMUST00000070166.6
|
Gramd3
|
GRAM domain containing 3 |
chr11_+_72326337 | 4.66 |
ENSMUST00000076443.10
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr9_+_74860133 | 4.65 |
ENSMUST00000215370.2
|
Fam214a
|
family with sequence similarity 214, member A |
chr5_-_87240405 | 4.65 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr14_-_31362835 | 4.62 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chrX_+_36059274 | 4.62 |
ENSMUST00000016463.4
|
Slc25a5
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 |
chr4_+_138694422 | 4.62 |
ENSMUST00000116094.5
ENSMUST00000239443.2 |
Rnf186
|
ring finger protein 186 |
chr3_+_146302832 | 4.56 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr2_-_12424212 | 4.55 |
ENSMUST00000124603.8
ENSMUST00000129993.3 ENSMUST00000028105.13 |
Mindy3
|
MINDY lysine 48 deubiquitinase 3 |
chr10_-_128509764 | 4.50 |
ENSMUST00000054764.9
|
Suox
|
sulfite oxidase |
chr11_-_5865124 | 4.47 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chrX_+_138701544 | 4.47 |
ENSMUST00000054889.4
|
Cldn2
|
claudin 2 |
chr2_-_25351024 | 4.46 |
ENSMUST00000151239.2
|
Paxx
|
non-homologous end joining factor |
chr19_-_7943365 | 4.45 |
ENSMUST00000182102.8
ENSMUST00000075619.5 |
Slc22a27
|
solute carrier family 22, member 27 |
chr6_+_88701810 | 4.43 |
ENSMUST00000089449.5
|
Mgll
|
monoglyceride lipase |
chr15_+_82336535 | 4.42 |
ENSMUST00000089129.7
ENSMUST00000229313.2 ENSMUST00000231136.2 |
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr8_+_86219191 | 4.41 |
ENSMUST00000034136.12
|
Gpt2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
chr9_-_9239056 | 4.40 |
ENSMUST00000093893.12
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr6_+_124489364 | 4.39 |
ENSMUST00000068593.9
|
C1ra
|
complement component 1, r subcomponent A |
chr5_-_87572060 | 4.36 |
ENSMUST00000072818.6
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr6_+_88701578 | 4.35 |
ENSMUST00000150180.4
ENSMUST00000163271.8 |
Mgll
|
monoglyceride lipase |
chr6_-_85809064 | 4.34 |
ENSMUST00000032073.7
|
Nat8
|
N-acetyltransferase 8 (GCN5-related) |
chr11_+_83637766 | 4.27 |
ENSMUST00000070832.3
|
Wfdc21
|
WAP four-disulfide core domain 21 |
chr2_+_58645189 | 4.26 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr8_+_89423645 | 4.23 |
ENSMUST00000043526.15
ENSMUST00000211554.2 ENSMUST00000209532.2 ENSMUST00000209559.2 |
Cyld
|
CYLD lysine 63 deubiquitinase |
chr6_+_88701470 | 4.22 |
ENSMUST00000113581.8
|
Mgll
|
monoglyceride lipase |
chr6_+_121323577 | 4.21 |
ENSMUST00000032200.16
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr13_+_9143916 | 4.21 |
ENSMUST00000188211.8
ENSMUST00000188939.7 ENSMUST00000190041.7 |
Larp4b
|
La ribonucleoprotein domain family, member 4B |
chr17_-_13179187 | 4.20 |
ENSMUST00000159697.2
|
Acat2
|
acetyl-Coenzyme A acetyltransferase 2 |
chr18_+_21077627 | 4.20 |
ENSMUST00000050004.3
|
Rnf125
|
ring finger protein 125 |
chr10_-_81127057 | 4.19 |
ENSMUST00000045744.7
|
Tjp3
|
tight junction protein 3 |
chr2_+_71884943 | 4.18 |
ENSMUST00000028525.6
|
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr5_+_87148697 | 4.15 |
ENSMUST00000031186.9
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr15_+_100202079 | 4.15 |
ENSMUST00000230252.2
ENSMUST00000231166.2 |
Mettl7a1
|
methyltransferase like 7A1 |
chr16_+_13758494 | 4.15 |
ENSMUST00000141971.8
ENSMUST00000124947.8 ENSMUST00000023360.14 ENSMUST00000143697.8 |
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr4_+_102112189 | 4.15 |
ENSMUST00000106908.9
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr7_+_131012330 | 4.14 |
ENSMUST00000015829.15
ENSMUST00000117518.2 ENSMUST00000133277.4 |
Acadsb
|
acyl-Coenzyme A dehydrogenase, short/branched chain |
chr18_+_50261268 | 4.14 |
ENSMUST00000025385.7
|
Hsd17b4
|
hydroxysteroid (17-beta) dehydrogenase 4 |
chr2_+_122607157 | 4.13 |
ENSMUST00000005953.11
|
Sqor
|
sulfide quinone oxidoreductase |
chr11_-_84058292 | 4.09 |
ENSMUST00000050771.8
|
Gm11437
|
predicted gene 11437 |
chr17_+_44445659 | 4.08 |
ENSMUST00000239215.2
|
Clic5
|
chloride intracellular channel 5 |
chr9_-_66882669 | 4.07 |
ENSMUST00000215172.2
ENSMUST00000034929.7 |
Lactb
|
lactamase, beta |
chr2_-_73216743 | 4.05 |
ENSMUST00000112044.8
ENSMUST00000112043.8 ENSMUST00000076463.12 |
Gpr155
|
G protein-coupled receptor 155 |
chr18_-_60881679 | 4.04 |
ENSMUST00000237783.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr2_+_43445359 | 4.03 |
ENSMUST00000050511.7
|
Kynu
|
kynureninase |
chr1_+_88139678 | 4.02 |
ENSMUST00000073049.7
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr3_+_89366632 | 4.02 |
ENSMUST00000107410.8
|
Pmvk
|
phosphomevalonate kinase |
chr17_+_64907697 | 3.99 |
ENSMUST00000086723.10
|
Man2a1
|
mannosidase 2, alpha 1 |
chr19_-_8109346 | 3.97 |
ENSMUST00000065651.5
|
Slc22a28
|
solute carrier family 22, member 28 |
chr10_+_93324624 | 3.96 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr9_-_9238905 | 3.95 |
ENSMUST00000215397.2
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr2_-_27136826 | 3.93 |
ENSMUST00000149733.8
|
Sardh
|
sarcosine dehydrogenase |
chr8_-_72966663 | 3.93 |
ENSMUST00000098630.5
|
Cib3
|
calcium and integrin binding family member 3 |
chr2_+_43445333 | 3.93 |
ENSMUST00000028223.9
ENSMUST00000112826.8 |
Kynu
|
kynureninase |
chr3_+_89366425 | 3.91 |
ENSMUST00000029564.12
|
Pmvk
|
phosphomevalonate kinase |
chr18_-_39623698 | 3.91 |
ENSMUST00000115567.8
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr8_+_46111703 | 3.88 |
ENSMUST00000134675.8
ENSMUST00000139869.8 ENSMUST00000126067.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_+_11943265 | 3.88 |
ENSMUST00000025590.11
|
Osbp
|
oxysterol binding protein |
chr19_-_7780025 | 3.87 |
ENSMUST00000065634.8
|
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr3_+_137983250 | 3.85 |
ENSMUST00000004232.10
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr17_-_24428351 | 3.84 |
ENSMUST00000024931.6
|
Ntn3
|
netrin 3 |
chr7_-_48497771 | 3.84 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr11_+_72326391 | 3.84 |
ENSMUST00000100903.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr10_+_62860094 | 3.78 |
ENSMUST00000124784.8
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr17_+_35658131 | 3.77 |
ENSMUST00000071951.14
ENSMUST00000116598.10 ENSMUST00000078205.14 ENSMUST00000076256.8 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr3_+_118355778 | 3.76 |
ENSMUST00000039177.12
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr2_+_58644922 | 3.76 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chrX_+_139565657 | 3.74 |
ENSMUST00000112990.8
ENSMUST00000112988.8 |
Mid2
|
midline 2 |
chr9_-_21838584 | 3.73 |
ENSMUST00000213698.2
|
Tmem205
|
transmembrane protein 205 |
chr14_-_66246652 | 3.73 |
ENSMUST00000059970.9
|
Gulo
|
gulonolactone (L-) oxidase |
chr11_+_77409392 | 3.67 |
ENSMUST00000147386.2
|
Abhd15
|
abhydrolase domain containing 15 |
chr2_-_164699462 | 3.67 |
ENSMUST00000109316.8
ENSMUST00000156255.8 ENSMUST00000128110.2 ENSMUST00000109317.10 ENSMUST00000059954.14 |
Pltp
|
phospholipid transfer protein |
chr13_+_46822992 | 3.66 |
ENSMUST00000099547.4
|
Fam8a1
|
family with sequence similarity 8, member A1 |
chr2_-_25351106 | 3.66 |
ENSMUST00000114261.9
|
Paxx
|
non-homologous end joining factor |
chr14_+_40826970 | 3.66 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr4_+_140966810 | 3.65 |
ENSMUST00000141834.9
|
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr4_-_124744454 | 3.64 |
ENSMUST00000125776.8
ENSMUST00000163946.2 ENSMUST00000106190.10 |
1110065P20Rik
|
RIKEN cDNA 1110065P20 gene |
chr7_-_97228589 | 3.63 |
ENSMUST00000151840.2
ENSMUST00000135998.8 ENSMUST00000144858.8 ENSMUST00000146605.8 ENSMUST00000072725.12 ENSMUST00000138060.3 ENSMUST00000154853.8 ENSMUST00000136757.8 ENSMUST00000124552.3 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr1_-_65218217 | 3.62 |
ENSMUST00000097709.11
|
Idh1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chr7_+_48895879 | 3.61 |
ENSMUST00000064395.13
|
Nav2
|
neuron navigator 2 |
chr10_+_127595639 | 3.59 |
ENSMUST00000128247.2
|
Rdh16f1
|
RDH16 family member 1 |
chr6_+_125297596 | 3.58 |
ENSMUST00000176655.8
ENSMUST00000176110.8 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr14_+_55798362 | 3.58 |
ENSMUST00000072530.11
ENSMUST00000128490.9 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr11_+_87482971 | 3.57 |
ENSMUST00000103179.10
ENSMUST00000092802.12 ENSMUST00000146871.8 |
Mtmr4
|
myotubularin related protein 4 |
chr3_+_94600863 | 3.57 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chr1_-_179373826 | 3.55 |
ENSMUST00000027769.6
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr19_+_26582450 | 3.54 |
ENSMUST00000176769.9
ENSMUST00000208163.2 ENSMUST00000025862.15 ENSMUST00000176030.8 |
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr11_+_72326358 | 3.48 |
ENSMUST00000108499.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr10_-_71180763 | 3.47 |
ENSMUST00000045887.9
|
Cisd1
|
CDGSH iron sulfur domain 1 |
chr10_+_107107558 | 3.46 |
ENSMUST00000105280.5
|
Lin7a
|
lin-7 homolog A (C. elegans) |
chr13_+_9143995 | 3.42 |
ENSMUST00000091829.4
|
Larp4b
|
La ribonucleoprotein domain family, member 4B |
chr19_+_32597379 | 3.41 |
ENSMUST00000236290.2
ENSMUST00000025833.7 |
Papss2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr1_-_136888118 | 3.40 |
ENSMUST00000192357.6
ENSMUST00000027649.14 |
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr9_+_77829191 | 3.40 |
ENSMUST00000133757.8
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr19_+_4036562 | 3.38 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr17_-_59320257 | 3.38 |
ENSMUST00000174122.2
ENSMUST00000025065.12 |
Nudt12
|
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
chr5_-_87288177 | 3.37 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr14_+_51328534 | 3.36 |
ENSMUST00000022428.13
ENSMUST00000171688.9 |
Rnase4
Ang
|
ribonuclease, RNase A family 4 angiogenin, ribonuclease, RNase A family, 5 |
chr9_-_79700789 | 3.35 |
ENSMUST00000120690.2
|
Tmem30a
|
transmembrane protein 30A |
chr2_-_80411724 | 3.33 |
ENSMUST00000111760.3
|
Nckap1
|
NCK-associated protein 1 |
chr9_-_35028100 | 3.33 |
ENSMUST00000034537.8
|
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.2 | 39.6 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
8.2 | 24.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
5.1 | 35.9 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
4.8 | 24.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.8 | 19.3 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
4.3 | 13.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
3.2 | 9.7 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
3.2 | 9.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.2 | 12.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
3.2 | 19.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
3.1 | 9.2 | GO:0009087 | methionine catabolic process(GO:0009087) |
2.9 | 8.8 | GO:0070237 | positive regulation of activation-induced cell death of T cells(GO:0070237) |
2.7 | 8.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
2.4 | 7.3 | GO:0038190 | cell migration involved in vasculogenesis(GO:0035441) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) sensory neuron axon guidance(GO:0097374) |
2.3 | 6.9 | GO:0071938 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
2.3 | 11.3 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
2.2 | 6.6 | GO:0006212 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
2.2 | 10.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.1 | 29.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
2.0 | 7.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.8 | 5.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
1.8 | 7.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.8 | 16.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.8 | 7.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.8 | 12.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.8 | 12.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
1.8 | 9.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.8 | 7.2 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
1.8 | 26.5 | GO:0015747 | urate transport(GO:0015747) |
1.8 | 12.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.8 | 8.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.5 | 9.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.5 | 22.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.5 | 4.5 | GO:0042128 | nitrate assimilation(GO:0042128) |
1.4 | 6.9 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
1.3 | 28.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.3 | 3.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.3 | 5.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.3 | 3.8 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
1.2 | 6.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.2 | 3.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.2 | 7.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.2 | 3.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 5.7 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.1 | 20.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.1 | 12.4 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
1.1 | 4.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.1 | 10.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
1.0 | 6.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.0 | 35.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
1.0 | 8.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.0 | 9.9 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
1.0 | 3.0 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
1.0 | 2.0 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
1.0 | 8.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.0 | 9.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.0 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.0 | 2.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 4.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.9 | 2.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.9 | 6.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.9 | 3.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.9 | 2.7 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.9 | 29.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.9 | 3.6 | GO:0021918 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.9 | 3.5 | GO:0007522 | visceral muscle development(GO:0007522) |
0.9 | 6.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.9 | 3.5 | GO:0006547 | histidine biosynthetic process(GO:0000105) histidine metabolic process(GO:0006547) 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.9 | 2.6 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.9 | 3.5 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.9 | 4.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.9 | 2.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.9 | 3.4 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.9 | 2.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.9 | 1.7 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.9 | 2.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.8 | 4.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.8 | 5.9 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 1.7 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
0.8 | 2.4 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.8 | 20.9 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.8 | 3.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 3.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 8.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 5.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.7 | 2.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.7 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 2.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 3.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 2.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.7 | 4.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.7 | 2.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.7 | 2.1 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.7 | 4.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 4.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 2.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.7 | 2.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.7 | 14.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 4.8 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.7 | 2.7 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.7 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.7 | 5.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 4.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 12.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.6 | 1.9 | GO:0001966 | thigmotaxis(GO:0001966) |
0.6 | 4.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.6 | 5.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 6.9 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.6 | 1.9 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.6 | 7.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.6 | 1.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.6 | 4.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.6 | 2.4 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.6 | 8.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.6 | 1.8 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.6 | 8.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.6 | 6.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.7 | GO:0019405 | hexitol metabolic process(GO:0006059) alditol catabolic process(GO:0019405) |
0.6 | 3.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 1.7 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 3.4 | GO:0032430 | diacylglycerol biosynthetic process(GO:0006651) positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 6.1 | GO:1903797 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.6 | 5.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.6 | 2.2 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.6 | 2.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 7.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 4.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 3.8 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.5 | 3.8 | GO:0015862 | uridine transport(GO:0015862) |
0.5 | 1.6 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.5 | 3.2 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.5 | 7.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.6 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.5 | 6.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 1.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 2.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.5 | 2.5 | GO:0015867 | ATP transport(GO:0015867) |
0.5 | 4.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 1.5 | GO:0072249 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.5 | 1.5 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
0.5 | 2.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 2.4 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 2.9 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 3.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 6.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.5 | 2.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 10.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.5 | 1.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 3.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 1.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.5 | 1.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.5 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.5 | 0.5 | GO:0002458 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.5 | 1.4 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 1.8 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.4 | 1.3 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.4 | 7.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.4 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.4 | 6.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.4 | 2.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 2.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.4 | 1.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 0.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.4 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 1.2 | GO:1903699 | tarsal gland development(GO:1903699) |
0.4 | 1.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.4 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 1.2 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.4 | 1.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.6 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.4 | 1.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.4 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 6.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 3.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.1 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.4 | 1.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 1.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.4 | 2.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.4 | 3.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 10.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.4 | 2.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 3.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 2.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 2.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 4.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 1.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 4.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 2.0 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) positive regulation of triglyceride lipase activity(GO:0061365) |
0.3 | 3.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 2.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 2.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 3.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.0 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.3 | 1.3 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
0.3 | 2.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 1.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.9 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.3 | 1.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.2 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.3 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 2.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 3.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 3.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 1.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 2.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) positive regulation of intracellular mRNA localization(GO:1904582) |
0.3 | 2.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 4.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.3 | 1.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 3.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 0.3 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.3 | 1.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 2.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 3.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 1.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.8 | GO:0042262 | DNA protection(GO:0042262) |
0.3 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.1 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 0.8 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.3 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.3 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 1.1 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.3 | 1.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.8 | GO:1901420 | cell migration involved in endocardial cushion formation(GO:0003273) negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.3 | 9.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 2.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 1.0 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.3 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.2 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 1.5 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.2 | 1.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 1.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 1.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 1.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 1.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 3.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 1.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 1.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.7 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 2.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 5.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.7 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 2.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 2.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 2.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 1.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 1.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 3.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 2.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 9.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.8 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 5.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 1.4 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 6.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 2.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 2.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.2 | 1.4 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.4 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.4 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 9.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) protein localization to nuclear pore(GO:0090204) |
0.2 | 0.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 4.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 1.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 1.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 1.1 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
0.2 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 3.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 7.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 2.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 5.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 2.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 2.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 0.7 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 5.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 4.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 2.1 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.4 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 0.3 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.2 | 3.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.5 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.3 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.2 | 3.6 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 1.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 2.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 3.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 3.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 2.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 3.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 1.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.5 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.2 | 10.3 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.2 | 2.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 3.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 3.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 2.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.5 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.2 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 2.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 2.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.9 | GO:0015824 | L-alanine transport(GO:0015808) proline transport(GO:0015824) |
0.2 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 1.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 1.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 1.9 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:0060667 | orbitofrontal cortex development(GO:0021769) fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) coronal suture morphogenesis(GO:0060365) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.1 | 0.4 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.1 | 0.1 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.1 | 0.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 4.8 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.1 | 1.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 1.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 4.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 1.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 4.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 2.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.8 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 2.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.8 | GO:0051611 | regulation of serotonin uptake(GO:0051611) |
0.1 | 5.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.4 | GO:0061300 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) cerebellum vasculature development(GO:0061300) |
0.1 | 3.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 2.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 10.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.4 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 1.6 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.1 | 1.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 3.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 2.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 1.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.9 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.6 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 0.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 2.9 | GO:0015918 | sterol transport(GO:0015918) |
0.1 | 0.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 1.0 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.1 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.1 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.3 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.1 | 0.2 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.1 | 0.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 3.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 3.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 3.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 1.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 7.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 1.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 1.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 1.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 3.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 1.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 1.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 2.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 1.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 4.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.1 | 1.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 6.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 4.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 7.3 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) mitral valve formation(GO:0003192) tricuspid valve formation(GO:0003195) |
0.1 | 1.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.3 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 1.3 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 1.8 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 1.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.7 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 3.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 1.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 1.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 1.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 2.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 1.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.1 | 0.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.3 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.8 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 4.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.1 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 0.4 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 2.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.5 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 4.7 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 1.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 1.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 1.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 2.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.5 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.6 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.0 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 1.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.4 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.4 | GO:1901727 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.7 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.0 | 0.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 1.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.6 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 1.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.6 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
0.0 | 0.3 | GO:0070627 | ferrous iron import(GO:0070627) |
0.0 | 2.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 1.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 2.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 1.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.8 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.0 | 0.1 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.1 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.2 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.0 | 2.9 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 4.0 | GO:0009636 | response to toxic substance(GO:0009636) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 1.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 3.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 1.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.0 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 1.0 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 1.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0014862 | regulation of the force of skeletal muscle contraction(GO:0014728) regulation of skeletal muscle contraction by chemo-mechanical energy conversion(GO:0014862) |
0.0 | 0.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.2 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.0 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 2.5 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 35.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
3.6 | 32.0 | GO:0005579 | membrane attack complex(GO:0005579) |
2.6 | 20.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.2 | 10.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.0 | 8.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.4 | 4.3 | GO:0005715 | late recombination nodule(GO:0005715) |
1.4 | 8.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.2 | 19.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 3.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
1.1 | 21.0 | GO:0045180 | basal cortex(GO:0045180) |
1.1 | 5.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.0 | 3.1 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.9 | 5.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 4.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.9 | 8.7 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 3.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.8 | 4.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 6.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 9.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 3.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 19.4 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 7.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 2.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.7 | 6.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 7.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.7 | 8.0 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 1.9 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 2.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 2.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.6 | 6.3 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 22.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.5 | 2.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 4.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.4 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.5 | 1.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.4 | 1.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 6.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 23.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 2.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 2.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 5.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.4 | 9.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 1.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 4.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 4.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 5.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 2.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.0 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 1.7 | GO:0035841 | new growing cell tip(GO:0035841) |
0.3 | 3.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.2 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 2.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.8 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 2.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 0.9 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.3 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.3 | 1.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 4.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 3.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 2.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 9.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 10.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 61.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.0 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.2 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) symmetric synapse(GO:0032280) |
0.2 | 3.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.8 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 4.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.2 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.2 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 3.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.2 | 0.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 5.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 9.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 3.2 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 1.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 3.3 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 12.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.3 | GO:0071914 | prominosome(GO:0071914) |
0.2 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 4.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 2.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.1 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 13.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 4.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 3.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 6.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 4.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 7.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 52.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 4.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.4 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.1 | 0.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 6.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 7.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 8.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 13.1 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 12.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 2.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.0 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 9.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 4.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.1 | 0.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 13.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 1.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 121.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 7.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 3.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 57.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 1.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 4.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 39.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
6.2 | 24.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
5.0 | 30.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
4.3 | 21.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
3.1 | 12.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
2.8 | 11.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.8 | 2.8 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
2.7 | 8.0 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
2.3 | 9.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
2.2 | 22.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
2.2 | 6.6 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
2.1 | 8.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
2.1 | 12.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
2.0 | 8.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.9 | 78.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.9 | 5.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.9 | 11.3 | GO:0008142 | oxysterol binding(GO:0008142) |
1.8 | 7.4 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.8 | 9.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.7 | 29.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.7 | 5.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.5 | 5.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.4 | 6.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.4 | 5.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 8.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.3 | 4.0 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
1.3 | 3.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.3 | 3.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.2 | 8.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.2 | 7.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
1.2 | 3.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.2 | 8.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 7.0 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
1.2 | 3.5 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
1.1 | 18.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 3.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.1 | 3.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.1 | 9.8 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
1.0 | 5.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.0 | 6.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.0 | 3.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
1.0 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 6.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 1.9 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.0 | 2.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 2.9 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.9 | 12.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 14.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.9 | 1.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 20.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.9 | 3.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.9 | 6.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.9 | 6.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 18.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.9 | 9.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 4.4 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.9 | 3.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.9 | 3.4 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.8 | 10.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.8 | 5.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 3.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 2.4 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.8 | 3.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.8 | 4.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 33.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 2.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.7 | 2.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.7 | 2.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.1 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.7 | 2.1 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.7 | 2.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.7 | 4.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.7 | 7.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.7 | 4.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 2.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.7 | 2.6 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.6 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 3.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.6 | 1.9 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.6 | 4.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 1.8 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.6 | 2.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.6 | 5.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 2.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 4.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 1.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.6 | 1.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 3.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 6.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 2.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.5 | 5.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 4.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 3.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.5 | 3.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 5.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 10.3 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 5.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.5 | 1.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.5 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.5 | 2.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 18.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 3.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 2.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.4 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 2.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 12.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.4 | 3.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 1.7 | GO:0009041 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.4 | 1.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.4 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 2.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 10.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.4 | 1.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.9 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.4 | 1.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 2.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.4 | 5.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 3.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 2.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 14.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 4.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 2.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 9.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 6.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.3 | 1.4 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 2.4 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.0 | GO:0070540 | stearic acid binding(GO:0070540) |
0.3 | 4.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 6.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 8.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 2.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 1.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 1.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.9 | GO:0070404 | NADH binding(GO:0070404) |
0.3 | 2.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 0.9 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.3 | 3.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 2.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 2.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 2.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 1.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.3 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.3 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 0.8 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.3 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.1 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.3 | 3.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 2.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.3 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 6.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.2 | 2.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 4.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 1.5 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.2 | 13.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 3.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 7.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.7 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.7 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.2 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 2.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 3.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.7 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.2 | 1.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.7 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.2 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.7 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.2 | 0.9 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.2 | 0.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 5.0 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 5.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 3.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.6 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 5.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 2.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.5 | GO:0008127 | quercetin 2,3-dioxygenase activity(GO:0008127) |
0.2 | 0.5 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 8.5 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 3.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 2.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 4.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 3.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 2.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 1.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 5.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 9.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 6.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 1.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 5.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 6.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 4.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 2.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 1.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 4.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.8 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 4.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 2.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 4.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 1.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 1.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 16.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 1.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.2 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.1 | 2.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 3.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 1.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 2.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 12.6 | GO:0005253 | anion channel activity(GO:0005253) |
0.1 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 4.8 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 2.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 4.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 1.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 3.9 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.2 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.5 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 10.7 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 1.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.1 | 4.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 8.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 5.4 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 4.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 12.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 4.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 1.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.0 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 1.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 2.7 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 2.1 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.0 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 2.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 2.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0001602 | peptide YY receptor activity(GO:0001601) pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 40.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 7.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 38.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 41.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 17.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 6.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 9.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 6.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 4.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 3.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 5.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 2.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 56.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.5 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
1.2 | 3.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.2 | 17.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 32.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 13.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.9 | 11.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 24.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.8 | 9.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 1.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.8 | 27.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.8 | 12.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 14.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 7.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 27.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 16.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 12.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 22.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.4 | 10.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 8.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 13.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 10.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 10.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 5.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 34.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 10.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 8.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 5.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 1.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 23.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 6.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 8.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 4.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 9.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 38.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 4.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 4.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 9.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 6.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 6.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 4.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 5.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 6.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 4.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 4.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 5.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 5.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 9.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 6.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 4.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 5.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 6.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 4.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.9 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 3.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 3.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 3.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |